Rchr
J-GLOBAL ID:202001009641225723   Update date: Jan. 25, 2025

Ishida Joji

イシダ ジョウジ | Ishida Joji
Affiliation and department:
Job title: 助教
Research theme for competitive and other funds  (8):
  • 2024 - 2027 空間発現解析による脳腫瘍の形態診断と遺伝子診断の統合による悪性化マーカーの検索
  • 2024 - 2027 腸脳相関によるサイトカインを中心とした膠芽腫Cancer Stem Cell Theoryの解明
  • 2024 - 2027 HDAC阻害薬によるtumor ecosystemの打破と、新規併用療法への応用
  • 2023 - 2026 Novel fluorescent labeling system for brain tumor surgery and its therapeutic application
  • 2023 - 2026 Therapeutic approach to overcome the blood-brain barrier barrier for pediatric brainstem gliomas.
Show all
Papers (64):
  • Tsuyoshi Umeda, Yoshihiro Otani, Kentaro Fujii, Joji Ishida, Shuichiro Hirano, Yasuki Suruga, Naoya Kemmotsu, Ryoji Imoto, Yasuhito Kegoya, Ryo Mizuta, et al. Identification of factors related to functional prognoses in craniopharyngiomas. Journal of neuro-oncology. 2025
  • Toshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara, Masaki Magari, Ai Miyamoto, Youki Ueda, Takamasa Ishino, Joji Nagasaki, Tomohiro Fujiwara, Hidetaka Yamamoto, et al. Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy. Cancer research. 2025
  • Yoshihiro Otani, Fumiyo Higaki, Kentaro Fujii, Joji Ishida, Yosuke Shimazu, Shuichiro Hirano, Naoya Kemmotsu, Yasuki Suruga, Ryoji Imoto, Ryo Mizuta, et al. Comparative analysis of intraoperative MRI and early postoperative MRI findings in glioma surgery patients. Journal of neurosurgery. 2024. 1-9
  • Ryo Mizuta, Keigo Makino, Yoshihiro Otai, Kentaro Fujii, Joji Ishida, Atsuhito Uneda, Nobushige Tsuboi, Shuichiro Hirano, Naoya Kemmotsu, Yasuki Suruga, et al. TMIC-31. MOLECULAR PROGNOSTIC FACTORS OF THE PROGRESSION OF VESTIBULAR SCHWANNOMA AFTER PRIMARY TUMOR RESECTION. Neuro-Oncology. 2024. 26. Supplement_8. viii304-viii305
  • Yoshihiro Otani, Yasuhiko Hattori, Atsuhito Uneda, Nobushige Tsuboi, Keigo Makino, Shuichiro Hirano, Joji Ishida, Kentaro Fujii, Yusuke Tomita, Tetsuo Oka, et al. EXTH-04. COMBINATION OF BEVACIZUMAB ENHANCES THE ANTI-TUMOR EFFICACY OF AD-SGE-REIC FOR GLIOMA. Neuro-Oncology. 2024. 26. Supplement_8. viii236-viii237
more...
MISC (57):
  • 金恭平, 安原隆雄, 石田穣治, 春間純, 三宅隼人, 平田雄一, 永瀬喬之, 菅原千明, 佐々田晋, 杉生憲志. 慢性硬膜下血腫治療後の治療抵抗性硬膜下膿瘍に対して保存的加療を行った一例. 日本脳神経外傷学会プログラム・抄録集. 2024. 47th
  • 駿河和城, 大谷理浩, 松本悠司, 石田穣治, 井上陽平, 平野秀一郎, 藤井謙太郎, 柳井広之, 山本英喜, 里見介史, et al. Analysis of the tumor microenvironment in NF1-related gliomas. 小児の脳神経(Web). 2024. 49. 2
  • 中島 拓真, 舟越 勇介, 畝田 篤仁, 田中 將太, 石田 穣治, 齋藤 竜太, 花谷 亮典, 吉本 幸司, 成田 善孝, 鈴木 啓道. がんゲノム診断とバイオインフォマティクス 大規模全ゲノムおよびトランスクリプトーム解析によるGlioblastoma,IDH-wild typeの多様性の解明. Brain Tumor Pathology. 2023. 40. Suppl. 066-066
  • 道上宏之, 道上宏之, 坪井伸成, 坪井伸成, 大谷理浩, 畝田篤仁, 駿河和城, 松本悠司, 石田穣治, 藤井謙太郎, et al. New anti-angiogenic therapy with the anti-depressant toward tumor derived endothelial cells (TDECs). 日本脳腫瘍学会学術集会プログラム・抄録集. 2023. 41st
  • 梅田剛志, 大谷理浩, 松本悠司, 松本悠司, 井上陽平, 外間まどか, 水田亮, 井本良二, 駿河和城, 劒持直也, et al. Elucidation of the Molecular Biological Mechanisms Regulating Phenotypic Shift in Glioblastoma. 日本脳腫瘍学会学術集会プログラム・抄録集. 2023. 41st
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page